公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2015 | The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old | Kuo C.-C.; Balakrishnan P.; Hsein Y.-C.; VIN-CENT WU ; SHIH-CHIEH CHUEH ; YUNG-MING CHEN ; KWAN-DUN WU ; MING-JIUH WANG ; YEN-HUNG LIN ; YI-LWUN HO ; Chang H.-W.; LIAN-YU LIN ; Hu F.-C.; KAO-LANG LIU ; SHUO-MENG WANG ; KUO-HOW HUANG ; CHIN-CHEN CHANG ; CHING-CHU LU ; Shih-Cheng Liao ; RUOH-FANG YEN ; WEI-CHOU LIN ; Hsieh, Bor-Sen; TAIPAI group | JRAAS - Journal of the Renin-Angiotensin-Aldosterone System | 9 | 6 | |
2001 | Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer | Su S.-S.; Che T.-C.; RUOH-FANG YEN ; She Y.-Y.; Changla S.-P.; Kao A. | Anticancer Research | 70 | 58 | |
2001 | Whole body positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer | RUOH-FANG YEN ; Sun S.-S.; Shen Y.-Y.; Changlai S.-P.; Kao A. | Anticancer Research | 65 | 48 | |
2005 | Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma | RUOH-FANG YEN ; RUEY-LONG HONG ; KAI-YUAN TZEN ; Pan M.-H.; HSIU-HSI CHEN | Journal of Nuclear Medicine | 52 | 41 | |
2007 | Whole-body F-18 FDG PET for hepatocellular carcinoma patients after interventional treatment | MEI-FANG CHENG ; YEN-WEN WU ; KAI-YUAN TZEN ; Huang Y.-H.; RUOH-FANG YEN | Neoplasma | 9 | 6 |